Brainstorm cell therapeutics announces promotion of dr. stacy lindborg to co-chief executive officer

New york , jan. 4, 2023 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the promotion of dr. stacy lindborg to the role of co-chief executive officer. this promotion launches a targeted capability build which will be led by dr. lindborg, to hire and bring expertise inside brainstorm, preparing for success.
BCLI Ratings Summary
BCLI Quant Ranking